GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Lukang Pharmaceutical Co Ltd (SHSE:600789) » Definitions » Additional Paid-In Capital

Shandong Lukang Pharmaceutical Co (SHSE:600789) Additional Paid-In Capital : ¥0 Mil(As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Lukang Pharmaceutical Co Additional Paid-In Capital?


Shandong Lukang Pharmaceutical Co's quarterly additional paid-in capital increased from Mar. 2024 (¥0 Mil) to Jun. 2024 (¥1,267 Mil) but then stayed the same from Jun. 2024 (¥1,267 Mil) to Sep. 2024 (¥0 Mil).

Shandong Lukang Pharmaceutical Co's annual additional paid-in capital declined from Dec. 2021 (¥1,208 Mil) to Dec. 2022 (¥1,201 Mil) but then increased from Dec. 2022 (¥1,201 Mil) to Dec. 2023 (¥1,261 Mil).


Shandong Lukang Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Shandong Lukang Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Lukang Pharmaceutical Co Additional Paid-In Capital Chart

Shandong Lukang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,209.63 1,206.03 1,208.07 1,200.80 1,260.72

Shandong Lukang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,260.72 - 1,266.63 -

Shandong Lukang Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Shandong Lukang Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shandong Lukang Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Lukang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 152 Taibai West Road, Jining, Shandong, CHN, 272021
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.
Executives
Zhao Wei Director
Peng Xin Director
Dong Kun Director
He De Feng senior management
Gao Xiang You Director
Cheng Jun Director

Shandong Lukang Pharmaceutical Co Headlines

No Headlines